5
Trans Asia Corporation Ltd(Liquidated)
530783 BSE
Trans Asia Corporation Ltd(Liquidated)
Healthcare BSE: 530783 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
3- Stock is trading at 3.97 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -2.75% over last 3 years.
Growth Rate
Net Income Growth
-75%
Quarterly Results
| Particulars | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.04 | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 | 0.08 |
| Operating Profit | -0.01 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -0.02 | -0.08 |
| Other Income | 0 | 0 | 0 | 0 | -1.17 | 0 | 0 | 0 | 0 | 0 | 0 | -5.44 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.01 | -0.04 | -0.01 | -0.01 | -1.19 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -5.46 | -0.08 |
| Tax % | 0% | 0% | 0% | 0% | 6.72% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.01 | -0.04 | -0.01 | -0.01 | -1.27 | -0.04 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -5.46 | -0.08 |
| EPS in Rs | -0.02 | -0.08 | -0.02 | -0.02 | -2.44 | -0.08 | -0.02 | -0.02 | -0.04 | -0.08 | -0.02 | -10.48 | -0.15 |
Profit & Loss
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.37 | 10.69 | 0.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 38.34 | 10.89 | 0.44 | 0.02 | 0.02 | 0.03 | 0.04 | 0.07 | 0.05 | 0.06 | 0.08 | 0.15 |
| Operating Profit | 0.03 | -0.2 | -0.03 | -0.02 | -0.02 | -0.03 | -0.04 | -0.07 | -0.05 | -0.06 | -0.08 | -0.15 |
| OPM % | 0.08% | -1.87% | -7.32% | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | -0.31 | -0.02 | 0 | 0 | 0.04 | 0 | 0 | -1.17 | 0 | -5.44 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.02 | -0.21 | -0.35 | -0.05 | -0.03 | -0.03 | 0 | -0.07 | -0.06 | -1.23 | -0.08 | -5.59 |
| Tax % | 0% | 0% | -20% | 40% | 66.67% | 66.67% | — | 0% | 0% | 6.5% | 0% | 0% |
| Net Profit | 0.02 | -0.21 | -0.28 | -0.07 | -0.05 | -0.04 | -0.02 | -0.07 | -0.06 | -1.31 | -0.08 | -5.59 |
| EPS in Rs | 0.04 | -0.4 | -0.54 | -0.13 | -0.1 | -0.08 | -0.04 | -0.13 | -0.12 | -2.51 | -0.15 | -10.73 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 | 5.21 |
| Reserves | 3.06 | 2.85 | 2.57 | 2.5 | 2.45 | 2.35 | 2.33 | 2.25 | 2.2 | 0.88 | 0.8 | -4.79 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0 |
| Other Liabilities | 10.24 | 0.31 | 0.85 | 0.63 | 0.48 | 0.09 | 0.56 | 0.54 | 0.51 | 0.64 | 0.6 | 0.2 |
| Total Liabilities | 18.51 | 8.37 | 8.63 | 8.34 | 8.14 | 7.65 | 8.1 | 8 | 7.92 | 6.73 | 6.76 | 0.62 |
| Fixed Assets | 0.11 | 0.1 | 0.09 | 0.08 | 0.07 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.18 | 1.21 | 1.2 | 1.17 | 1.17 | 1.18 | 1.18 | 1.18 | 1.32 | 0.15 | 0.15 | 0 |
| Other Assets | 17.22 | 7.06 | 7.34 | 7.09 | 6.9 | 6.46 | 6.92 | 6.82 | 6.6 | 6.58 | 6.61 | 0.62 |
| Total Assets | 18.51 | 8.37 | 8.63 | 8.34 | 8.14 | 7.65 | 8.1 | 8 | 7.92 | 6.73 | 6.76 | 0.62 |
Cash Flow
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.04 | 0.02 | -0.02 | -0.01 | 0 | 0 | -0.12 | 1.57 | 0.13 | 0.01 | 0.66 | 0.62 |
| Investing | 0.03 | -0.04 | 0 | 0 | 0 | 0 | 0 | -1.57 | -0.12 | -0.02 | -0.66 | 0 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | -0.15 |
| Net Cash Flow | -0.01 | -0.02 | -0.02 | -0.01 | 0 | 0 | -0.02 | 0 | 0.01 | -0.01 | 0 | 0.47 |
| Free Cash Flow | -0.04 | 0.02 | -0.02 | -0.01 | 0 | 0 | -0.12 | 1.57 | 0.13 | 0.01 | 0.66 | 0.62 |
| CFO/OP | -133 | -10 | 67 | 50 | 0 | 0 | 300 | -2,243 | -260 | -17 | -825 | -413 |
Ratios
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129 | 120 | 3,988 | — | — | — | — | — | — | — | — | — |
| Inventory Days | 4.7 | 14 | 0 | — | — | — | — | — | — | — | — | — |
| Days Payable | 97.26 | 2.05 | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 36.33 | 132 | 3,988 | — | — | — | — | — | — | — | — | — |
| Working Capital Days | 62.5 | 132 | 3,436 | — | — | — | — | — | — | — | — | — |
| ROCE % | 0.24% | -2.57% | -0.51% | -0.39% | -0.39% | -0.39% | 0% | -0.93% | -0.67% | -0.89% | -1.31% | -4.26% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Trans Asia Corporation Ltd(Liquidated) insights
61 extracted metrics + investor summaries across FY09–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 Feb - Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of Physical Shares is attached herewith. 24 Feb - Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of Physical Shares is attached herewith.
2
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
20 Feb - Written Transcript of Earnings Conference Call held on February 16, 2026 at 04:30 PM is attached herewith. 20 Feb - Written Transcript of Earnings Conference Call held on February 16, 2026 at 04:30 PM is attached herewith.
3
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16 Feb - Audio recording of Feb 16, 2026 4:30pm earnings call uploaded; transcript forthcoming. 16 Feb - Audio recording of Feb 16, 2026 4:30pm earnings call uploaded; transcript forthcoming.
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Feb - Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025 is attached herewith 14 Feb - Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025 is attached herewith
5
Announcement under Regulation 30 (LODR)-Acquisition
13 Feb - Board approved unaudited Q3/9M results; subscribed 378,350 Selvax shares (AUD0.20), consideration USD50,000. 13 Feb - Board approved unaudited Q3/9M results; subscribed 378,350 Selvax shares (AUD0.20), consideration USD50,000.
Frequently Asked Questions about Trans Asia Corporation Ltd(Liquidated)
What does Trans Asia Corporation Ltd(Liquidated) do?
Trans Asia Corporation is primarily engaged in plastic products and other commodities.
Where is Trans Asia Corporation Ltd(Liquidated) (530783) listed?
Trans Asia Corporation Ltd(Liquidated) trades under code 530783 on the BSE.
Which sector does Trans Asia Corporation Ltd(Liquidated) belong to?
Trans Asia Corporation Ltd(Liquidated) is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
Trans Asia Corporation is primarily engaged in plastic products and other commodities.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530783.md for Trans Asia Corporation Ltd(Liquidated): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.